Similarly, it would be desirable to include other biomarkers (e.g., metabolism, oxidative stress, and neurotrophins) to validate the potential effect of exacerbations on the clinical course of psychiatric disorders and T2DM. This evidence concerns the gene BDNF and psychiatric disorder.